FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966805280> ?p ?o ?g. }

• W1966805280 endingPage "778" @default.
• W1966805280 startingPage "773" @default.
• W1966805280 abstract "C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy.BackgroundThe inflammatory marker C-reactive protein (CRP) has been found in most, but not all, prospective studies to be associated with future cardiovascular outcomes. However, CRP has not been tested in the high-cardiovascular risk population of type 2 diabetic nephropathy.MethodsWe studied the independent relationship between CRP and the subsequent development of incident or recurrent arteriosclerotic outcomes (primary) and congestive heart failure events (secondary) in 1560 individuals with diabetic nephropathy, overt proteinuria, and hypertension enrolled in the prospective Irbesartan Diabetic Nephropathy Trial.ResultsTraditional cardiac risk factors were highly prevalent, CRP levels were high overall [quintiles (mg/L) 1st, 0 to 1.2; 2nd, 1.3 to 2.5; 3rd, 2.6 to 5.0; 4th, 5.1 to 10.0; and 5th, >10), and subsequent cardiovascular events were very common. A univariate relationship existed between CRP and total arteriosclerotic outcomes (P < 0.0001). However, after adjusting for study intervention and traditional risk factors, the relationship no longer remained. In fact, controlling for previous cardiovascular disease alone caused the association to become nonsignificant. The secondary analysis found a significant univariate relationship between CRP and congestive heart failure events (P = 0.007) that persisted in multivariate analyses (P = 0.006). However, this relationship was confined to the highest CRP quintile [RR (95% CI) 2.0 (1.27, 3.16)].ConclusionIn diabetic patients with nephropathy, CRP does not add predictive information above and beyond that provided by traditional established risk factors. Whether this holds true for other populations with similar risk burdens is an important public health question that should be addressed. A secondary finding of a link between CRP and congestive heart failure requires further confirmation. C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy. The inflammatory marker C-reactive protein (CRP) has been found in most, but not all, prospective studies to be associated with future cardiovascular outcomes. However, CRP has not been tested in the high-cardiovascular risk population of type 2 diabetic nephropathy. We studied the independent relationship between CRP and the subsequent development of incident or recurrent arteriosclerotic outcomes (primary) and congestive heart failure events (secondary) in 1560 individuals with diabetic nephropathy, overt proteinuria, and hypertension enrolled in the prospective Irbesartan Diabetic Nephropathy Trial. Traditional cardiac risk factors were highly prevalent, CRP levels were high overall [quintiles (mg/L) 1st, 0 to 1.2; 2nd, 1.3 to 2.5; 3rd, 2.6 to 5.0; 4th, 5.1 to 10.0; and 5th, >10), and subsequent cardiovascular events were very common. A univariate relationship existed between CRP and total arteriosclerotic outcomes (P < 0.0001). However, after adjusting for study intervention and traditional risk factors, the relationship no longer remained. In fact, controlling for previous cardiovascular disease alone caused the association to become nonsignificant. The secondary analysis found a significant univariate relationship between CRP and congestive heart failure events (P = 0.007) that persisted in multivariate analyses (P = 0.006). However, this relationship was confined to the highest CRP quintile [RR (95% CI) 2.0 (1.27, 3.16)]. In diabetic patients with nephropathy, CRP does not add predictive information above and beyond that provided by traditional established risk factors. Whether this holds true for other populations with similar risk burdens is an important public health question that should be addressed. A secondary finding of a link between CRP and congestive heart failure requires further confirmation." @default.
• W1966805280 created "2016-06-24" @default.
• W1966805280 creator A5008205347 @default.
• W1966805280 creator A5040493032 @default.
• W1966805280 creator A5086343659 @default.
• W1966805280 creator A5088716375 @default.
• W1966805280 date "2005-08-01" @default.
• W1966805280 modified "2023-10-14" @default.
• W1966805280 title "C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy" @default.
• W1966805280 cites W1970548566 @default.
• W1966805280 cites W1981554819 @default.
• W1966805280 cites W2008785889 @default.
• W1966805280 cites W2018705986 @default.
• W1966805280 cites W2027415701 @default.
• W1966805280 cites W2043998851 @default.
• W1966805280 cites W2044773944 @default.
• W1966805280 cites W2052121574 @default.
• W1966805280 cites W2056976690 @default.
• W1966805280 cites W2058709767 @default.
• W1966805280 cites W2061252559 @default.
• W1966805280 cites W2086098465 @default.
• W1966805280 cites W2087042442 @default.
• W1966805280 cites W2097573767 @default.
• W1966805280 cites W2109348687 @default.
• W1966805280 cites W2110837983 @default.
• W1966805280 cites W2115276193 @default.
• W1966805280 cites W2120309176 @default.
• W1966805280 cites W2121893515 @default.
• W1966805280 cites W2126045082 @default.
• W1966805280 cites W2135568455 @default.
• W1966805280 cites W2145053304 @default.
• W1966805280 cites W2316376271 @default.
• W1966805280 cites W2331274940 @default.
• W1966805280 doi "https://doi.org/10.1111/j.1523-1755.2005.00456.x" @default.
• W1966805280 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16014055" @default.
• W1966805280 hasPublicationYear "2005" @default.
• W1966805280 type Work @default.
• W1966805280 sameAs 1966805280 @default.
• W1966805280 citedByCount "19" @default.
• W1966805280 countsByYear W19668052802014 @default.
• W1966805280 countsByYear W19668052802015 @default.
• W1966805280 countsByYear W19668052802016 @default.
• W1966805280 countsByYear W19668052802017 @default.
• W1966805280 countsByYear W19668052802022 @default.
• W1966805280 crossrefType "journal-article" @default.
• W1966805280 hasAuthorship W1966805280A5008205347 @default.
• W1966805280 hasAuthorship W1966805280A5040493032 @default.
• W1966805280 hasAuthorship W1966805280A5086343659 @default.
• W1966805280 hasAuthorship W1966805280A5088716375 @default.
• W1966805280 hasBestOaLocation W19668052801 @default.
• W1966805280 hasConcept C126322002 @default.
• W1966805280 hasConcept C134018914 @default.
• W1966805280 hasConcept C144301174 @default.
• W1966805280 hasConcept C164705383 @default.
• W1966805280 hasConcept C188816634 @default.
• W1966805280 hasConcept C2776174234 @default.
• W1966805280 hasConcept C2776914184 @default.
• W1966805280 hasConcept C2777180221 @default.
• W1966805280 hasConcept C2778198053 @default.
• W1966805280 hasConcept C2779134260 @default.
• W1966805280 hasConcept C2779561371 @default.
• W1966805280 hasConcept C2779922275 @default.
• W1966805280 hasConcept C2780091579 @default.
• W1966805280 hasConcept C2781184683 @default.
• W1966805280 hasConcept C2781195455 @default.
• W1966805280 hasConcept C2908647359 @default.
• W1966805280 hasConcept C38180746 @default.
• W1966805280 hasConcept C555293320 @default.
• W1966805280 hasConcept C71924100 @default.
• W1966805280 hasConcept C99454951 @default.
• W1966805280 hasConceptScore W1966805280C126322002 @default.
• W1966805280 hasConceptScore W1966805280C134018914 @default.
• W1966805280 hasConceptScore W1966805280C144301174 @default.
• W1966805280 hasConceptScore W1966805280C164705383 @default.
• W1966805280 hasConceptScore W1966805280C188816634 @default.
• W1966805280 hasConceptScore W1966805280C2776174234 @default.
• W1966805280 hasConceptScore W1966805280C2776914184 @default.
• W1966805280 hasConceptScore W1966805280C2777180221 @default.
• W1966805280 hasConceptScore W1966805280C2778198053 @default.
• W1966805280 hasConceptScore W1966805280C2779134260 @default.
• W1966805280 hasConceptScore W1966805280C2779561371 @default.
• W1966805280 hasConceptScore W1966805280C2779922275 @default.
• W1966805280 hasConceptScore W1966805280C2780091579 @default.
• W1966805280 hasConceptScore W1966805280C2781184683 @default.
• W1966805280 hasConceptScore W1966805280C2781195455 @default.
• W1966805280 hasConceptScore W1966805280C2908647359 @default.
• W1966805280 hasConceptScore W1966805280C38180746 @default.
• W1966805280 hasConceptScore W1966805280C555293320 @default.
• W1966805280 hasConceptScore W1966805280C71924100 @default.
• W1966805280 hasConceptScore W1966805280C99454951 @default.
• W1966805280 hasIssue "2" @default.
• W1966805280 hasLocation W19668052801 @default.
• W1966805280 hasLocation W19668052802 @default.
• W1966805280 hasOpenAccess W1966805280 @default.
• W1966805280 hasPrimaryLocation W19668052801 @default.
• W1966805280 hasRelatedWork W2047244276 @default.
• W1966805280 hasRelatedWork W2049230880 @default.
• W1966805280 hasRelatedWork W2061298156 @default.

• next